Post-Bariatric Patients See More Benefits With Semaglutide vs ...

MedPage Today - 08 Mar 2023
Semaglutide users also more likely to experience weight loss, retrospective study suggests.

‘Watershed Moment’: Semaglutide Effective in MASH

Medscape - 21 Nov 2024
‘Watershed Moment’: Semaglutide Effective in MASH ...

Drugs Like Ozempic May Have a Shrinking Effect on The Heart

ScienceAlert - 22 Nov 2024
Drugs Like Ozempic May Have a Shrinking Effect on The Heart ...

Weight Loss Drug Shrinks Heart Muscle in Mouse and Human Cells

Technology Networks - 21 Nov 2024
Weight Loss Drug Shrinks Heart Muscle in Mouse and Human Cells ...

The Effect of Lifestyle Coaching Design on Patient Engagement and Weight Loss in Non-diabetic Patients of a Semaglutide-Supported Digital Obesity Program in the UK: A Comparative Retrospective Cohort Study

Cureus - 23 Nov 2024
The Effect of Lifestyle Coaching Design on Patient Engagement and Weight Loss in Non-diabetic Patients of a Semaglutide-Supported Digital Obesity Program in the UK: A Comparative Retrospective Cohort Study ...

Researchers estimate 136M Americans eligible for Ozempic

The Hill - 20 Nov 2024
Researchers estimate 136M Americans eligible for Ozempic ...

Ozempic has been a medical breakthrough – but the online risks remain

inews - 22 Nov 2024
Ozempic has been a medical breakthrough – but the online risks remain ...

Don't fall for fake Ozempic: Sahpra urges caution and how to detect counterfeits and stay safe

News24 - 21 Nov 2024
Don't fall for fake Ozempic: Sahpra urges caution and how to detect counterfeits and stay safe ...

6 Promising Health Benefits of Weight Loss Drugs

Newsmax - 22 Nov 2024
6 Promising Health Benefits of Weight Loss Drugs ...

Could Ozempic be our next tool in fighting the overdose crisis? Surprising research suggests so

Salon - 21 Nov 2024
Could Ozempic be our next tool in fighting the overdose crisis? Surprising research suggests so ...

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Salon - 21 Nov 2024
Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices ...

More than half of U.S. adults eligible for semaglutide treatment

EMS1.com - 23 Nov 2024
More than half of U.S. adults eligible for semaglutide treatment ...

ESSENCE Phase 3 trial results demonstrating statistically significant and superior improvements with semaglutide 2.4 mg in people with MASH presented at AASLD 2024 - The Liver Meeting®

PR Newswire - 19 Nov 2024
ESSENCE Phase 3 trial results demonstrating statistically significant and superior improvements with semaglutide 2.4 mg in people with MASH presented at AASLD 2024 - The Liver Meeting® ...

Semaglutide